1
|
Caputo M, Daffara T, Ferrero A, Romanisio M, Monti E, Mele C, Zavattaro M, Tricca S, Siani A, Clemente A, Palumbo C, De Cillà S, Carriero A, Volpe A, Marzullo P, Aimaretti G, Prodam F. Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature? J Endocrinol Invest 2024; 47:377-387. [PMID: 37466811 PMCID: PMC10859343 DOI: 10.1007/s40618-023-02154-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2023] [Accepted: 07/05/2023] [Indexed: 07/20/2023]
Abstract
PURPOSE The uncertainty on the management of small adrenal incidentalomas (AIs) still represents a challenge in real clinical practice. Considering the lack of knowledge on risk factors implicated in tumour enlargement, the aim of this study was to identify risk factors for morphological changes during follow-up of adrenal incidentalomas (AIs). METHODS We retrospectively evaluated demographic, clinical, radiological and biochemical parameters of 153 AIs (2007-2021). Patients with histological diagnosis of metastases or pheochromocytoma were excluded. To detect risk factors for tumor enlargement, diseases associated with AIs were included if their prevalence was higher than 2%. Patients were divided into two groups (A: radiological stability; B: tumor enlargement defined as > 5 mm/year in the main diameter). RESULTS Group A: 89.5% and group B: 10.5%, mean follow-up 38.6 ± 6.9 months (range 6-240). Tumor enlargement when occurred was within 36 months of follow-up. In group B high body weight (p < 0.03), dehydroepiandrosterone sulfate (DHEAS) (p < 0.05) and direct renin concentration (DRC) (p < 0.04) were higher than group A, while aldosterone levels were lower; moreover, considering comorbidities, glaucoma and dysglycemia (p < 0.01 for both) had higher prevalence in group B. Glaucoma and dysglycemia were independent predictors of enlargement. Patients affected by glaucoma, atrial fibrillation, dysglycemia had a lower dimensional change-free survival than non-affected. CONCLUSIONS Glaucoma might be a novel risk factor for AI enlargement. If subtle undetectable cortisol hypersecretion has a role is a topic for further research.
Collapse
Affiliation(s)
- M Caputo
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy.
- Department of Health Sciences, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy.
| | - T Daffara
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy
| | - A Ferrero
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy
| | - M Romanisio
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy
| | - E Monti
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy
| | - C Mele
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy
| | - M Zavattaro
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy
| | - S Tricca
- Department of Diagnostic and Interventional Radiology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
| | - A Siani
- Department of Diagnostic and Interventional Radiology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
| | - A Clemente
- Ophthalmology Unit, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy
| | - C Palumbo
- Division of Urology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
| | - S De Cillà
- Ophthalmology Unit, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy
| | - A Carriero
- Department of Diagnostic and Interventional Radiology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
| | - A Volpe
- Division of Urology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
| | - P Marzullo
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy
| | - G Aimaretti
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy
| | - F Prodam
- Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy
- Department of Health Sciences, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy
| |
Collapse
|
2
|
Greco C, Passerini F, Coluccia S, Teglio M, Bondi M, Mecheri F, Trapani V, Volpe A, Toschi P, Madeo B, Simoni M, Rochira V, Santi D. Long-term trajectories of bone metabolism parameters and bone mineral density (BMD) in obese patients treated with metabolic surgery: a real-world, retrospective study. J Endocrinol Invest 2023; 46:2133-2146. [PMID: 36971952 DOI: 10.1007/s40618-023-02066-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Accepted: 03/09/2023] [Indexed: 03/29/2023]
Abstract
PURPOSE Potential negative effects of metabolic surgery on skeletal integrity remain a concern, since long-term data of different surgical approaches are poor. This study aimed to describe changes in bone metabolism in subjects with obesity undergoing both Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG). METHODS A single center, retrospective, observational clinical study on real-world data was performed enrolling subjects undergoing metabolic surgery. RESULTS 123 subjects were enrolled (males 31: females 92; ages 48.2 ± 7.9 years). All patients were evaluated until 16.9 ± 8.1 months after surgery, while a small group was evaluated up to 4.5 years. All patients were treated after surgery with calcium and vitamin D integration. Both calcium and phosphate serum levels significantly increased after metabolic surgery and remained stable during follow-up. These trends did not differ between RYGB and SG (p = 0.245). Ca/P ratio decreased after surgery compared to baseline (p < 0.001) and this decrease remained among follow-up visits. While 24-h urinary calcium remained stable across all visits, 24-h urinary phosphate showed lower levels after surgery (p = 0.014), also according to surgery technique. Parathyroid hormone decreased (p < 0.001) and both vitamin D (p < 0.001) and C-terminal telopeptide of type I collagen (p = 0.001) increased after surgery. CONCLUSION We demonstrated that calcium and phosphorous metabolism shows slight modification even after several years since metabolic surgery, irrespective of calcium and vitamin D supplementation. This different set point is characterized by a phosphate serum levels increase, together with a persistent bone loss, suggesting that supplementation alone may not ensure the maintenance of bone health in these patients.
Collapse
Affiliation(s)
- C Greco
- Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Giardini, 1355, 41126, Modena, Italy
- Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy
| | - F Passerini
- Division of Internal Medicine and Metabolism, Department of Internal Medicine, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy
- Unit of Internal and Metabolic Medicine, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - S Coluccia
- Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Giardini, 1355, 41126, Modena, Italy
- Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy
| | - M Teglio
- Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Giardini, 1355, 41126, Modena, Italy
| | - M Bondi
- Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy
| | - F Mecheri
- Division of General, Emergency Surgery and New Technologies, Ospedale Civile di Baggiovara, Modena, Italy
| | - V Trapani
- Division of General, Emergency Surgery and New Technologies, Ospedale Civile di Baggiovara, Modena, Italy
| | - A Volpe
- Division of General, Emergency Surgery and New Technologies, Ospedale Civile di Baggiovara, Modena, Italy
| | - P Toschi
- Department of Metabolic Diseases and Clinical Nutrition, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy
| | - B Madeo
- Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Giardini, 1355, 41126, Modena, Italy
- Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy
| | - M Simoni
- Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Giardini, 1355, 41126, Modena, Italy
- Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy
| | - V Rochira
- Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Giardini, 1355, 41126, Modena, Italy.
- Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy.
| | - D Santi
- Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Giardini, 1355, 41126, Modena, Italy
- Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy
| |
Collapse
|
3
|
Paiè P, Volpe A, Li M. Editorial: Particle manipulation in microfluidic devices. Front Bioeng Biotechnol 2022; 10:1087299. [DOI: 10.3389/fbioe.2022.1087299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 11/23/2022] [Indexed: 12/03/2022] Open
|
4
|
Conte E, Chiesa M, Mushtaq S, Schillaci M, Marchetti D, Baggiano A, Volpe A, Colombo G, Pompilio G, Bartorelli A, Pontone G, Andreini D. Deep learning applied to facial features for prediction of high risk coronary atherosclerosis at cardiac CT: preliminary data from LOMBROSO Trial. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cardiac computed tomography (CT) emerged as an accurate tool for non-invasive evaluation of coronary artery disease (CAD), being able to identify high risk non-calcified atherosclerosis. Identification of high risk CAD in its asymptomatic stage could be an interest target for medical therapy. Nowadays no validated tools are available to predict the presence of high risk atherosclerosis, probably due to the multifactorial pathogenesis of atherosclerosis. Facial features may express both genetic and environmental factors that could be associated to high risk atherosclerosis. Aim of the present study was to verify whether deep learning models applied to facial features may accurately predict the presence of high risk coronary atherosclerosis evaluated at cardiac CT
Methods
We enrolled a consecutive cohort of patients who underwent clinical indicated cardiac CT for suspected, CAD. Before CT, 10 facial photos were taken from every patients from random fronts views.
All cardiac CT were analysed for the presence of non-calcified plaque volume (defined as <150 HU at CT); the non-calcified plaque volume was quantified on a per-patient basis in mm3 and a cut off of >23 mm3 was used to define a patients with an elevated volume non-calcified plaque
We built a deep learning model, exploiting the transfer learning technique; briefly, we implemented an “xception” architecture, joining a pre-trained convolutional part with a specific combination of dense layers, in which an output layer follows a hidden layer with 512 neurons and a dropout layer with a dropout rate=0.2. The batch size, the number of epochs and the learning rate were 16, 20, and 0.0001, respectively. A training set composed of 198 face images was fed into the model, while 20 face images served as test set for the prediction of the presence of elevated volume of non-calcified plaque from patients facial features.
Results
We present early results from the first 20 patients enrolled (12 male and 8 female, with mean age of 73±13 years old). In 9 patients cardiac CT resulted completely normal, while in 11 subjects the presence of coronary atherosclerosis was demonstrated. Among them, 9 patients presented non-calcified coronary atherosclerosis, while 6 had an elevated volume of non-calcified plaque.
On the test set, we obtained an accuracy, sensitivity, specificity, positive predictive value, negative predictive values and and AUC equal to 0.90, 1, 0.8, 0.83, 1, and 0.99, respectively for the prediction of the presence of an elevated volume of non-calcified plaque from facial features among all 20 patients enrolled.
Conclusions
Prediction of the presence of high risk atherosclerosis from deep learning models applied to facial features appeared to be feasible and promising. Our results may provide a useful tool for appropriate identification of patients that may merit to underwent cardiac CT, even if asymptomatic, for early identification of high risk atherosclerosis
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- E Conte
- IRCCS Monzino Cardiology Center , Milan , Italy
| | - M Chiesa
- IRCCS Monzino Cardiology Center , Milan , Italy
| | - S Mushtaq
- IRCCS Monzino Cardiology Center , Milan , Italy
| | - M Schillaci
- IRCCS Monzino Cardiology Center , Milan , Italy
| | - D Marchetti
- IRCCS Monzino Cardiology Center , Milan , Italy
| | - A Baggiano
- IRCCS Monzino Cardiology Center , Milan , Italy
| | - A Volpe
- IRCCS Monzino Cardiology Center , Milan , Italy
| | - G Colombo
- IRCCS Monzino Cardiology Center , Milan , Italy
| | - G Pompilio
- IRCCS Monzino Cardiology Center , Milan , Italy
| | | | - G Pontone
- IRCCS Monzino Cardiology Center , Milan , Italy
| | - D Andreini
- IRCCS Monzino Cardiology Center , Milan , Italy
| |
Collapse
|
5
|
Cavalli S, Bondonno G, Berra M, Poletti F, Portè F, Taurino M, Ceratti G, Billia M, Palumbo C, Volpe A. Combined robot-assisted and endoscopic treatment of ureteral strictures: a single center experience. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01150-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
6
|
Di Martino J, Pesce D, Sogni F, Nicolazzini M, Cavalli S, Palumbo C, Billia M, Volpe A. Effect of a standardized rehabilitation program on erectile function recovery after robot-assisted radical prostatectomy. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01012-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
7
|
Claps F, Pavan N, d’Altilia N, Maggi M, Checcucci E, Napolitano L, Morlacco A, Tafuri A, Palumbo C, Mazzon G, Del Giudice F, Campi R, Signorini C, Boeri L, Giannarini G, Esperto F, Tulone G, Finati M, Sica M, La Rocca R, Bignù C, Celentano G, Falagario U, Traunero F, Panunzio A, Zucchi A, Sciarra A, Liguori G, Busetto G, Bartoletti R, Simonato A, Minervini A, Papalia R, Scarpa R, Serni S, Montanari E, Carmignani L, Celia A, Volpe A, Antonelli A, Dal Moro F, Mirone V, Porpiglia F, Tubaro A, Cormio L, Carrieri G, Trombetta C. Predictors of residual tumor at re-staging transurethral resection for high-risk non-muscle invasive bladder cancer: insights from a large multi-institutional collaboration. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01227-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
8
|
Perri D, Bondonno G, Zacchero M, Cavalli S, Porte' F, Volpe A. Complex robot-assisted bladder diverticulectomy with endoscopic assistance. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01345-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
9
|
Serra De Oliveira Marconi L, Dabestani S, Ljungberg B, Volpe A, Fernandez-Pello S, Capitanio U, Lam T, D Stewart G, Beisland C, Klatte T, Kuusk T, Bex A. Local treatment of metastasis in metastatic RCC may have a significant survival effect across all risk of recurrence groups. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00461-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
10
|
Crocerossa F, Autorino R, Derweesh I, Carbonara U, Cantiello F, Damiano R, Rubio-Briones J, Roupret M, Breda A, Volpe A, Mir M. Management of renal cell carcinoma in transplant kidney: An individual patient data meta-analysis and evidence-based guide. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00312-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Palumbo C, Perri D, Zacchero M, Bondonno G, Di Martino J, D'Agate D, Volpe A. Risk of progression after nephrectomy for non-metastatic clear cell renal cell carcinoma: Comparison of the predictive ability of validated risk models. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00149-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
12
|
Claps F, Pavan N, D'Altilia N, Checcucci E, Napolitano L, Morlacco A, Tafuri A, Palumbo C, Boeri L, Tulone G, Bignù C, Liguori G, Busetto G, Simonato A, Montanari E, Carmignani L, Celia A, Volpe A, Antonelli A, Dal Moro F, Mirone V, Porpiglia F, Cormio L, Carrieri G, Trombetta C. Predictors of residual tumor at re-staging transurethral resection for high-risk non-muscle invasive bladder cancer: Insights from a large multi-institutional collaboration. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00237-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
13
|
Fallara G, Larcher A, Dabestani S, Fossati N, Järvinen P, Nisen H, Gudmundsson E, Lam T, Marconi L, Fernandéz-Pello S, Meijer R, Volpe A, Beisland C, Klatte T, Stewart G, Ljungberg B, Montorsi F, Bex A, Capitanio U. Impact of surgical approach (open vs. minimally invasive) on oncological outcomes after nephrectomy for localised renal cell carcinoma: a recur database project. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00995-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
14
|
Marchioro G, Perri D, Zacchero M, Poletti F, Palumbo C, De Angelis P, Beldì D, Terrone C, Krengli M, Billia M, Volpe A. Long-term outcomes of intraoperative radiation therapy during radical prostatectomy for high-risk prostate cancer. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00695-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
15
|
Palumbo C, Perri D, D’Agate D, Bondonno G, Zacchero M, Volpe A. Risk of progression after nephrectomy for non-metastatic clear cell renal cell carcinoma: comparison of the predictive ability of validated risk models. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00997-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
16
|
Fallara G, Larcher A, Dabestani S, Fossati N, Järvinen P, Nisen H, Gudmundsson E, Lam T, Marconi L, Fernandéz-Pello S, Meijer R, Volpe A, Beisland C, Klatte T, Stewart G, Ljungberg B, Montorsi F, Bex A, Capitanio U. Impact of surgical approach (open vs. minimally invasive) on oncological outcomes after nephrectomy for localized renal cell carcinoma: A RECUR database project. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00947-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
17
|
Perri D, Marchioro G, Bondonno G, Maso G, Porta C, Volpe A. Repeat partial nephrectomy for recurrence of Von Hippel-Lindau-related renal cell carcinoma in an autotransplanted kidney. Urol Case Rep 2020; 35:101553. [PMID: 33425683 PMCID: PMC7779319 DOI: 10.1016/j.eucr.2020.101553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2020] [Accepted: 12/24/2020] [Indexed: 11/25/2022] Open
Abstract
Von Hippel-Lindau disease predisposes to develop renal cell carcinoma (RCC). Treatment is frequently challenging due to presence of bilateral tumors and high risk of recurrence. We present the case of a VHL-patient with bilateral recurrence of clear-cell RCC after bilateral partial nephrectomy and autotransplantation on one side. Recurrence on the transplanted kidney was treated with repeat partial nephrectomy with good oncological and functional outcomes. This approach is feasible in centres with wide experience in partial nephrectomy and renal transplantation when minimally invasive tumor ablation is not indicated.
Collapse
Affiliation(s)
- D Perri
- Division of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore Della Carità Hospital, Novara, Italy
| | - G Marchioro
- Division of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore Della Carità Hospital, Novara, Italy
| | - G Bondonno
- Division of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore Della Carità Hospital, Novara, Italy
| | - G Maso
- Division of Urology, San Biagio di Domodossola Hospital, ASLVCO, Italy
| | - C Porta
- Division of Vascular Surgery, University of Eastern Piedmont, Maggiore Della Carità Hospital, Novara, Italy
| | - A Volpe
- Division of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore Della Carità Hospital, Novara, Italy
| |
Collapse
|
18
|
Umari P, Bondonno G, Di Martino J, Perri D, La Rocca A, D'agate D, Billia M, Volpe A. Complex robot-assisted vescico-vaginal fistula repair: A step by step approach. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35891-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
19
|
Perri D, Palumbo C, Zacchero M, Bondonno G, La Rocca A, Di Martino J, Portè F, Umari P, Volpe A. Assessment of patterns of progression of clear cell renal cell carcinoma after nephrectomy in a large single institutional series. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35504-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
20
|
La Rocca A, Bondonno G, Ceratti G, Zacchero M, Poletti F, Cavalli S, Billia M, Umari P, Volpe A. Robot-assisted surgical management of ureteral strictures: technical aspects and preliminary outcomes in a single centre series. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35418-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
21
|
Bravi C, Larcher A, Capitanio U, Montorsi F, Bertini R, Antonelli A, Siracusano S, Barale M, Gontero P, Bove P, Brunocilla E, Schiavina R, Da Pozzo L, Longo N, Montanari E, Porpiglia F, Simeone C, Volpe A, Ficarra V, Li Marzi V, Di Maida F, Mari A, Carini M, Minervini A. The healthier the patient, the longer the ischemia: Surgical implications for partial nephrectomy in the RECORd2 project. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)32646-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
22
|
Abu-Ghanem Y, Fernández-Pello S, Bex A, Ljungberg B, Albiges L, Dabestani S, Giles R, Hofmann F, Hora M, Kuczyk M, Kuusk T, Marconi L, Merseburger A, Tahbaz R, Staehler M, Volpe A, Powles T, Lam T, Bensalah K. Bias of available data makes it unreliable to compare outcomes of thermo-ablation versus surgery for the treatment of T1 renal tumours: A systematic review from the European Association of Urology Renal Cell Cancer Guideline Panel. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33805-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
23
|
Tellini R, Campi R, Mari A, Amparore D, Antonelli A, Brunocilla E, Capitanio U, Gontero P, Mirone V, Montanari E, Li Marzi V, Roscigno M, Montorsi F, Porpiglia F, Simeone C, Trombetta C, Artibani W, Volpe A, Ficarra V, Carini M, Minervini A. What are the predictors of oncocytoma histology at pathological analysis after partial nephrectomy for small renal masses? Insights from a large prospective multicentre study (RECORd2 project). EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33208-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
24
|
Becciolini A, Caccavale R, Parisi S, Giordano S, Bravi E, DI Donato E, Lumetti F, Andracco R, Ditto MC, Santilli D, Lucchini G, Volpe A, Marchetta A, Mozzani F, Sandri G, Girelli F, Arrigoni E, Fusaro E, Paroli M, Ariani A. FRI0085 RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.3198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:The recent introduction of ABP 501, an adalimumab biosimilar, in treatment of rheumatic diseases was supported by a comprehensive comparability exercise with its originator. On the other hand observational studies comparing adalimumab and ABP 501 in inflammatory arthritis are still lacking.Objectives:To compare the clinical outcomes of the treatment with adalimumab, both originator and biosimilar, in a large cohort of patients affected by autoimmune arthritis in a real life setting.Methods:We retrospectively analysed the baseline characteristics and the retention rate in a cohort of patients who received at least a course of adalimumab (originator or biosimilar ABP 501) in eight Rheumatology Units from January 2003 to January 2020. We stratified the study population according to biosimilar use. Descriptive data are presented by medians (interquartile range [IQR]) for continuous data or as numbers (percentages) for categorical data. Drug survival distribution curves were computed by the Kaplan-Meier method and compared by a stratified log-rank test. P values ≤0.05 were considered statistically significant.Results:764 patients (53.4% female, median age 55 [44-65] years, median disease duration 60 [25-149] months) treated with adalimumab were included in the analysis. 308 (40.3%) were affect by rheumatoid arthritis, 244 (31.9%) by psoriatic arthritis, and 212 (27.7%) by axial spondylarthritis. 558 (73%) were treated with adalimumab originator and 206 (27%) with ABP 501. Among the biosimilars 60 (29.1%) patients were naïve to adalimumab treatment. The overall 6-month retentions rate was 93.1%. The 6-month retention rate for adalimumab and ABP 501 were 93.3% and 91.2% respectively, without significant differences between the groups (p=0.541). Patients switching from originator to biosimilar showed and overall higher treatment survival when compared to naive (6-month retention rate 95% vs 90-4%), although it was not significant (p=0.179).Conclusion:In our retrospective study adalimumab originator and its biosimilar ABP 501 showed the same effectiveness. Patients switching from originator to biosimilar showed an higher retention rate when compared to naive.Disclosure of Interests:Andrea Becciolini Speakers bureau: Sanofi-Genzyme, UCB and AbbVie, rosalba caccavale: None declared, Simone Parisi: None declared, Salvatore Giordano: None declared, Elena Bravi: None declared, eleonora Di Donato: None declared, Federica Lumetti: None declared, Romina Andracco: None declared, Maria Chiara Ditto: None declared, Daniele Santilli: None declared, Gianluca Lucchini: None declared, Alessandro Volpe: None declared, Antonio Marchetta: None declared, Flavio Mozzani: None declared, Gilda Sandri: None declared, Francesco Girelli: None declared, eugenio arrigoni: None declared, Enrico Fusaro: None declared, marino paroli: None declared, Alarico Ariani: None declared
Collapse
|
25
|
Fruzzetti F, Cagnacci A, Primiero F, De Leo V, Bastianelli C, Bruni V, Caruso S, Di Carlo C, Farris M, Grandi G, Grasso A, Guida M, Meriggiola M, Paoletti AM, Cianci A, Nappi C, Volpe A. Contraception during Coronavirus-Covid 19 pandemia. Recommendations of the Board of the Italian Society of Contraception. EUR J CONTRACEP REPR 2020; 25:231-232. [PMID: 32436739 DOI: 10.1080/13625187.2020.1766016] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Purpose: The Italian Society of Contraception identified as one of its priorities the need to give recommendations on management of contraception during Coronavirus-Covid 19 pandemiaMaterials and methods: A concise communication was produced which summarises in an easy-to-read format suitable for clinicians the management of the different contraceptives mostly used. Information how to manage contraception in different conditions is presented.Results: Women may, in general, continue to use either intrauterine and or hormonal contraceptives. The use of condom should be added to any hormonal contraceptive, when the contraceptive efficacy is reduced or when women stop the contraceptive method.Conclusion: At the present time, during the Coronavirus-Covid 19 pandemia, no data contraindicate the use of intrauterine or hormonal contraceptives. Conversely the use of an appropriate contraception is advocate to prevent unintended pregnancies.
Collapse
Affiliation(s)
- F Fruzzetti
- Department of Obstetrics and Gynecology, University of Pisa, Pisa, Italy
| | - A Cagnacci
- Department of Obstetrics and Gynecology, University of Genova, Genova, Italy
| | - F Primiero
- Sapienza, University of Rome, Rome, Italy
| | - V De Leo
- Department of Obstetrics and Gynecology, University of Siena, Siena, Italy
| | - C Bastianelli
- Department of Gynecology, Obstetrics and Urology, Sapienza, University of Rome, Rome, Italy
| | - V Bruni
- Department of Obstetrics and Gynecology, University of Florence, Florence, Italy
| | - S Caruso
- Obstetrics and Gynecology Unit, Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy
| | - C Di Carlo
- Department of Obstetrics and Gynecology, "Magna Grecia" University, Catanzaro, Italy
| | - M Farris
- Sapienza, University of Rome & Italian Association for Demographic Education, Rome, Italy
| | - G Grandi
- Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy
| | - A Grasso
- Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy
| | - M Guida
- Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, University of Napoli Federico II, Napoli, Italy
| | - M Meriggiola
- Department of Obstetrics and Gynecology, University of Bologna, Bologna, Italy
| | - A M Paoletti
- Department of Surgical Sciences, Department of Obstetrics and Gynecology, University of Cagliari, Cagliari, Italy
| | - A Cianci
- Obstetrics and Gynecology Unit, Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy
| | - C Nappi
- Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, University of Napoli Federico II, Napoli, Italy
| | - A Volpe
- Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy
| |
Collapse
|
26
|
Romeo V, Sarno L, Volpe A, Ginocchio MI, Esposito R, Mainenti PP, Petretta M, Liuzzi R, D'Armiento M, Martinelli P, Brunetti A, Maurea S. US and MR imaging findings to detect placental adhesion spectrum (PAS) in patients with placenta previa: a comparative systematic study. Abdom Radiol (NY) 2019; 44:3398-3407. [PMID: 31435761 DOI: 10.1007/s00261-019-02185-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
PURPOSE To compare the performance US and MR in identifying placental adhesion spectrum (PAS) in placenta previa (PP) and to establish a potential method of image interpretation. METHODS US and MR examinations of 51 patients with PP were selected. The presence of imaging signs commonly used to detect PAS was assessed. Penalized logistic regression was performed considering histology as standard of reference; only signs statistically significant (p < 0.05) were considered for ROC and multivariate analysis. The probability of PAS according to the presence of US and/or MR signs was then assessed. RESULTS At univariate analysis, loss of retroplacental clear space, myometrial thinning (MT) and placenta lacunar spaces on US, intraplacental dark bands (IDBs), focal interruption of myometrial border (FIMB) and abnormal vascularity (AV) on MR were statistically significant (p < 0.01). Three diagnostic methods for PAS were then developed for both US and MR when at least one (Method 1), two (Method 2) or three (Method 3) imaging signs occurred, respectively. Method 2 for MR showed a significantly (p < 0.05) higher accuracy (91%) compared to the other methods. When MR IDBs and AV as well as IDBs and FIMB were present in combination with US MT the probability of PAS increased from 75 to 90% and from 80 to 91%, respectively. CONCLUSION MR demonstrated a higher diagnostic accuracy than US to detect PAS. However, since the combination of MR and US signs could improve the probability to detect PAS, a complementary diagnostic role of these techniques could be considered.
Collapse
Affiliation(s)
- V Romeo
- Department of Advanced Biomedical Sciences, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy.
| | - L Sarno
- Department of Neuroscience, Reproductive and Dentistry Sciences, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy
| | - A Volpe
- Department of Advanced Biomedical Sciences, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy
| | - M I Ginocchio
- Department of Advanced Biomedical Sciences, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy
| | - R Esposito
- Department of Neuroscience, Reproductive and Dentistry Sciences, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy
| | - P P Mainenti
- Institute of Biostructures and Bioimaging of the National Research Council (IBB-CNR), Naples, Italy
| | - M Petretta
- Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy
| | - R Liuzzi
- Institute of Biostructures and Bioimaging of the National Research Council (IBB-CNR), Naples, Italy
| | - M D'Armiento
- Department of Advanced Biomedical Sciences, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy
| | - P Martinelli
- Department of Neuroscience, Reproductive and Dentistry Sciences, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy
| | - A Brunetti
- Department of Advanced Biomedical Sciences, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy
| | - S Maurea
- Department of Advanced Biomedical Sciences, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy
| |
Collapse
|
27
|
Cagnacci A, Bastianelli C, Neri M, Cianci A, Benedetto C, Calanni L, Vignali M, De Leo V, Cicinelli E, Borrelli G, Volpe A. Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO). EUR J CONTRACEP REPR 2018; 23:393-399. [DOI: 10.1080/13625187.2018.1541080] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Affiliation(s)
- Angelo Cagnacci
- Clinica Ginecologica e Ostetrica, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
| | - Carlo Bastianelli
- Dipartimento di Scienze Ostetriche e Ginecologiche e Scienze Urologiche, La Sapienza Università di Roma, Rome, Italy
| | - Manuela Neri
- Clinica Ostetrica e Ginecologica, Dipartimento di Scienze Chirurgiche, Università degli Studi di Cagliari, Azienda Ospedaliero Universitaria di Cagliari, Policlinico Universitario Duilio Casula, Monserrato, Italy
| | - Antonio Cianci
- Dipartimento Chirurgia Generale e Specialità Medico Chirurgiche, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele, Catania, Italy
| | - Chiara Benedetto
- Dipartimeto di Scienze Chirurgiche, Università degli Studi di Torino, Turin, Italy
| | - Luana Calanni
- Clinica Ostetrica e Ginecologia, Ospedale Policlinico San Martino, Genoa, Italy
| | - Michele Vignali
- Dipartimento di Scienze Biomedicine per la Salute, Università degli Studi di Milano, Milan, Italy
| | - Vincenzo De Leo
- Dipartimento di Medicina Molecolare e dello Sviluppo, Azienda Ospedaliera Universitaria Senese, Siena, Italy
| | - Ettore Cicinelli
- 2° Unità Operativa di Ginecologia ed Ostetricia, Dipartimento di Medicina e Oncologia (DIMO), Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari, Italy
| | | | - Annibale Volpe
- Facoltà di Medicina e Chirurgia Materno-Infantili e dell’Adulto, Università degli Studi di Modena e Reggio Emilia, Modena, Italy
| | | |
Collapse
|
28
|
Kurtys E, Lim L, Man F, Volpe A, Fruhwirth G. In vivo tracking of CAR-T by [ 18 f]BF 4 - PET/CT in human breast cancer xenografts reveals differences in CAR-T tumour retention. Cytotherapy 2018. [DOI: 10.1016/j.jcyt.2018.02.042] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
29
|
Baird DT, Bajos N, Cleland J, Glasier A, La Vecchia C, Leridon H, Milsom I, Benagiano G, Bhattacharya S, Bhattacharya S, Crosignani PG, Evers JLH, Negri E, Volpe A. Why after 50 years of effective contraception do we still have unintended pregnancy? A European perspective. Hum Reprod 2018; 33:777-783. [DOI: 10.1093/humrep/dey089] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2017] [Accepted: 03/26/2018] [Indexed: 11/15/2022] Open
Affiliation(s)
| | - D T Baird
- Centre for Reproductive Biology, University of Edinburgh, UK
| | | | - J Cleland
- Department of Population Health, London School of Hygiene & Tropical Medicine, London, UK
| | - A Glasier
- Simpson Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK
| | - C La Vecchia
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
| | - H Leridon
- Directeur de recherche émérite, INED, / French Institute for Demographic Studies, Paris cedex, France
| | - I Milsom
- Department of Obstetrics and Gynaecologist, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
| | - G Benagiano
- London School of Hygiene & Tropical Medicine, London, UK
| | - S Bhattacharya
- Gynaecology, Obstetrics and Urology, Sapienza University of Rome, Policlinico Umberto I, Roma, Italy
| | - S Bhattacharya
- Professor of Reproductive Medicine, Head of Division of Applied Health Sciences and Director Institute of Applied Health Sciences, School of Medicine and Dentistry, University of Aberdeen, Aberdeen Maternity Hospital, Foresterhill, Aberdeen, UK
| | - P G Crosignani
- IRCCS Ca’ Granda Foundation, Maggiore Policlinico Hospital, Milano, Italy
| | - J L H Evers
- Maastricht University and Academisch ziekenhuis Maastricht, Dept. Obstetrics & Gynaecology, Maastricht, The Netherlands
| | - E Negri
- Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milano, Italy
| | - A Volpe
- Dipartimento Integrato Materno Infantile, Università di Modena, Modena, Italy
| |
Collapse
|
30
|
Sacco E, Pinto F, Tienforti D, Marangi F, Destito A, Racioppi M, Gardi M, Volpe A, Bassi P. Investigational Drug Therapies for Overactive Bladder Syndrome: The Potential Alternatives to Anticolinergics. Urologia 2018. [DOI: 10.1177/039156030907600301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Background Overactive bladder is a high prevalent and quality of life affecting disease. The mainstay of the medical therapy is represented by antimuscarinic drugs, but their side effects markedly affect patient compliance and prompt studies on novel investigational drugs. Methods A systematic literature search of peer-reviewed papers and meeting abstracts published by December 2008 was performed. PubMed databank was searched for original English articles, by using the following search terms: “overactive bladder” or “detrusor overactivity” or “urinary incontinence” and “treatment”, alone and linked to any potential molecular target or novel drug cited in the literature. Results Effective alternative pharmacological treatments are currently scarce, but many new promising compounds are emerging which target key molecular pathways involved in micturition control. The most promising potential therapeutic targets include central nervous system GABAergic inhibitory pathway, dopaminergic and serotoninergic systems, b-adrenoceptors and cAMP metabolism, nonadrenergic-noncholinergic mechanisms such as purinergic and neuropeptidergic systems, vanilloid receptor, bladder sensory nervous terminals, nonneuronal bladder signalling systems including urothelium and interstitial cells, prostanoids, Rho-kinase and different subtypes of potassium and calcium channels. Conclusions Despite the enormous amount of new biologic insight, very few novel pharmacological therapies seems to have passed the proof-of-concept clinical stage. The ultimate clinical utility of new drugs will depend on the ability to exploit tissue-specific differences and disease-related changes in molecular expression/function and to improve storage phase dysfunctions without interfering with the emptying phase. Further preclinical investigations and controlled clinical trials are urgently needed in this challenging field.
Collapse
Affiliation(s)
- E. Sacco
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università’ Cattolica del Sacro Cuore, Roma
| | - F. Pinto
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università’ Cattolica del Sacro Cuore, Roma
| | - D. Tienforti
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università’ Cattolica del Sacro Cuore, Roma
| | - F. Marangi
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università’ Cattolica del Sacro Cuore, Roma
| | - A. Destito
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università’ Cattolica del Sacro Cuore, Roma
| | - M. Racioppi
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università’ Cattolica del Sacro Cuore, Roma
| | - M. Gardi
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università’ Cattolica del Sacro Cuore, Roma
| | - A. Volpe
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università’ Cattolica del Sacro Cuore, Roma
| | - P.F. Bassi
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università’ Cattolica del Sacro Cuore, Roma
| |
Collapse
|
31
|
Abstract
Introduction Statistical data referring to sports-related traumas of the urinary tract are quite scarce; nevertheless, it is possible to draw general data on the relationship between sports and urological traumas. Methods Literature review of peer-reviewed articles published by May 2009. Results Urological traumas account for about 10% of all traumas, and about 13% of them is sports-related. Genitourinary traumas are among the most common cause of abdominal injuries in sports. Blunt injuries are more common than penetrating ones and renal injuries are by far the most common, followed by testicular injuries; ureters, bladder and penis injuries are much more infrequent. Considering chronic microtraumas, injuries of bulbar urethra are also common in sports that involve riding. Overall, the incidence of genitourinary trauma due to sports is low. Renal traumas in sports injuries usually consist of grade 1–11 lesions and usually do not require surgical treatment. Cycling is the sporting activity most commonly associated with genitourinary injuries, followed by winter sports, horse riding and contact/collision sports. Literature data suggest that significant injuries are rare also in athletes with only one testicle or kidney. General preventive measures against sport-related injuries, along with the use of protective cups for male external genitalia, are generally sufficient to reduce the incidence of urogenital trauma. Conclusions Overall, studies show that urogenital injuries are uncommon in team and individual sports, and that most of them are low-grade injuries. Participation in sports that involve the potential for contact or collision needs to be carefully assessed in the athletes with only one testicle or kidney, even though urogenital injuries should not preclude sports participation to an appropriately informed and counseled patient. Further research is needed to acquire more knowledge on genitourinary injuries according to age, sports type and technical skill.
Collapse
Affiliation(s)
- E. Sacco
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - F. Marangi
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - F. Pinto
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - A. D'Addessi
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - M. Racioppi
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - G. Gulino
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - A. Volpe
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - M. Gardi
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - P.F. Bassi
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| |
Collapse
|
32
|
Abstract
Clinical effectiveness of botulinum toxin (BTX) in the treatment of both neurogenic and idiopathic detrusor overactivity has been demonstrated in several studies. However, different protocols and techniques have been used by authors. Methods. Literature review on intradetrusor injection of BTX for detrusor overactivity. Results. The greatest clinical experience reports the use of 200 and 300 U Botox®. Available data suggest that clinical efficacy, duration, and the side effect profile is similar at these doses. Very few data, on the other hand, are available regarding the clinical outcomes using the Dysport® preparation; isolated reports support that efficacy is similar when using a dosing range of 500 to 1000 SU with increased risk of systemic side effects using 1000 SU. A variety of injection volumes was used, demonstrating similar efficacy and tolerability profile. Clinical effect duration extends six to ten months in the majority of studies. Data suggest that a repeated injection scheme proves successful in the vast majority of initial responders. Conclusions. Safety, effectiveness, specificity and reversibility make BTX a new attractive treatment modality for overactive bladder syndrome. However, more experience is needed to standardize the injection protocol with respect to therapeutic outcomes and adverse effects.
Collapse
Affiliation(s)
- E. Sacco
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università Cattolica del Sacro Cuore, Roma
| | - M. Paolillo
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università Cattolica del Sacro Cuore, Roma
| | - A. Totaro
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università Cattolica del Sacro Cuore, Roma
| | - F. Pinto
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università Cattolica del Sacro Cuore, Roma
| | - A. Volpe
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università Cattolica del Sacro Cuore, Roma
| | - M. Gardi
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università Cattolica del Sacro Cuore, Roma
| | - P.F. Bassi
- Urologia, Policlinico Universitario “Agostino Gemelli”, Università Cattolica del Sacro Cuore, Roma
| |
Collapse
|
33
|
Abstract
Introduction Prostatitis-like syndromes are high prevalent health problems and frequently considered by patients and physicians as strictly correlated to sports causing perineal compression. These syndromes and their relationships with sporting activities have been discussed in this report. Methods We reviewed peer-reviewed scientific articles published by May 2009 and searched according to the following term selection: prostatitis, pudendal nerve, sport, cycling. Results Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a major healthcare burden heavily affecting patients’ Quality of Life. No clear evidence of any direct etiologic relationship has been found in literature between prostatitis, either bacterial or non-bacterial, and sports activities. On the other hand, some types of sport causing perineal compression, such as cycling, can exacerbate symptoms of acute and chronic prostatitis; a temporary sport discontinuation is justified in these patients. CP/CPPS may be often caused by pudendal nerve entrapment (PNE). Prostatitis-like urogenital neuropathic pain together with voiding and sexual dysfunctions are the hallmark of PNE. A common feature is that flexion activities of the hip, such as climbing, squatting, cycling provoke or worsen urogenital pain or pelvic pain. Many of the patients with PNE are cyclists, played American football, lifted weights, or wrestled as teenagers and young adults. PNE represents the most common bicycling associated urogenital problems. Conclusions Overall, studies show that no causal relationship has been demonstrated between prostatitis and sporting activities. Conversely, urologists should be aware that sports involving vigorous hip flexion activities or prolonged perineal compression are a potential and not an infrequent cause of uroand rological symptoms caused by pudendal nerve entrapment.
Collapse
Affiliation(s)
- E. Sacco
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - A. Totaro
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - F. Marangi
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - F. Pinto
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - M. Racioppi
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - G. Gulino
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - A. Volpe
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - M. Gardi
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| | - P.F. Bassi
- Clinica Urologica, Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma
| |
Collapse
|
34
|
Volpe A, Racioppi M, D'Agostino D, Cappa E, Gardi M, Totaro A, Pinto F, Sacco E, Marangi F, Palermo G, Bassi P. Bladder Tumor Markers: A Review of the Literature. Int J Biol Markers 2018; 23:249-61. [DOI: 10.1177/172460080802300409] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Bladder cancer is among the top eight most frequent cancers. Its natural history is related to a combination of factors that impact on its aggressiveness. Cystoscopy and urine cytology are the currently used techniques for the diagnosis and surveillance of non-invasive bladder tumors. The sensitivity of urine cytology for diagnosis is not high, particularly in low-grade tumors. The combination of voided urine cytology and new diagnostic urine tests would be ideal for the diagnosis and follow-up of bladder cancer. However, in order to have some clinical utility, new diagnostic and/or prognostic markers should achieve better predictive capacity that the currently used diagnostic tools. None of the markers evaluated over the last years showed remarkable sensitivity or specificity for the identification of any of the diverse types of bladder cancer in clinical practice. The limitations of the known prognostic markers have led to the research of new molecular markers for early detection of bladder cancer. This research focused in particular on the discovery of biomarkers capable of reducing the need for periodic cystoscopies or, ideally, offering a non-invasive examination instead. In this review, we will examine various new markers of bladder cancer and their value in the diagnosis and follow-up of non-muscle-invasive bladder cancer. When compared with urine cytology, which showed the highest specificity, most of these markers demonstrated an increased sensitivity.
Collapse
Affiliation(s)
- A. Volpe
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| | - M. Racioppi
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| | - D. D'Agostino
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| | - E. Cappa
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| | - M. Gardi
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| | - A. Totaro
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| | - F. Pinto
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| | - E. Sacco
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| | - F. Marangi
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| | - G. Palermo
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| | - P.F. Bassi
- Department of Urology, The Catholic University School of Medicine, Rome - Italy
| |
Collapse
|
35
|
Capitanio U, Stewart G, Larcher A, Ouzaid I, Akdogan B, Roscigno M, Marszalek M, Dell'Oglio P, Salagierski M, Volpe A, Mir M, Kriegmair M, Terrone C, Brookman-May S, Montorsi F, Klatte T. European temporal trends in the use of lymph node dissection in patients with renal cancer. Eur J Surg Oncol 2017; 43:2184-2192. [DOI: 10.1016/j.ejso.2017.07.016] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2017] [Revised: 07/02/2017] [Accepted: 07/18/2017] [Indexed: 11/15/2022] Open
|
36
|
Gambacciani M, Biglia N, Cagnacci A, Caruso S, Cicinelli E, DE Leo V, DI Carlo C, Farris M, Gambera A, Guaschino S, Lanzone A, Paoletti AM, Russo N, Vicariotto F, Villa P, Volpe A. Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society. Minerva Obstet Gynecol 2017; 70:27-34. [PMID: 28975776 DOI: 10.23736/s0026-4784.17.04151-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Over the last decade, the risk benefits ratio of hormone replacement therapy (HRT) has been reevaluated mainly in tens of cardiovascular risk. Present Consensus Statement is largely inspired by the Global Consensus on Menopausal Hormone Therapy in 2013 and 2016 by leading global menopause societies (The American Society for Reproductive Medicine, The Asia Pacific Menopause Federation, The Endocrine Society, The European Menopause and Andropause Society, The International Menopause Society, The International Osteoporosis Foundation and The North American Menopause Society). The aim of these recommendations is to provide a simple and updated reference on postmenopausal HRT. The term HRT typically includes estrogen replacement therapy (ERT) and estrogen-progestogen therapy (EPT). EPT can be sequential, when progestogen is added to ERT for 10-14 days a month, or continuous combined when progestogen is administered continuously every day along with a fixed amount of estrogen, In the everyday language, HRT includes also tibolone and the tissue-selective estrogen complex.
Collapse
Affiliation(s)
- Marco Gambacciani
- Department of Obstetrics and Gynecology, Pisa University Hospital, Pisa, Italy -
| | | | - Angelo Cagnacci
- Department of Obstetrics Gynecology and Pediatrics, Azienda Sanitaria Universitaria Integrata Udine, Udine, Italy
| | - Salvatore Caruso
- Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy
| | - Ettore Cicinelli
- Department of Obstetrics and Gynecology, School of Medicine, University of Bari, Bari, Italy
| | - Vincenzo DE Leo
- Department of Obstetrics and Gynecology, University of Siena, Santa Maria le Scotte Polyclinic, Siena, Italy
| | - Costantino DI Carlo
- Department of Obstetrics and Gynecology, Magna Græcia University, Catanzaro, Italy
| | | | - Alessandro Gambera
- Department of Gynecological Endocrinology, University of Brescia, Brescia, Italy
| | | | - Antonio Lanzone
- Department of Obstetrics and Gynecology and Pediatrics, Sacro Cuore Catholic University, Rome, Italy
| | - Anna M Paoletti
- Department of Surgery, Obstetrics, and Gynecology, University of Cagliari, Cagliari University Hospital, Cagliari, Italy
| | | | | | - Paola Villa
- Department of Obstetrics and Gynecology and Pediatrics, Sacro Cuore Catholic University, Rome, Italy
| | | | | |
Collapse
|
37
|
Diocou S, Volpe A, Jauregui-Osoro M, Boudjemeline M, Chuamsaamarkkee K, Man F, Blower PJ, Ng T, Mullen GED, Fruhwirth GO. [ 18F]tetrafluoroborate-PET/CT enables sensitive tumor and metastasis in vivo imaging in a sodium iodide symporter-expressing tumor model. Sci Rep 2017; 7:946. [PMID: 28424464 PMCID: PMC5430436 DOI: 10.1038/s41598-017-01044-4] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2017] [Accepted: 03/22/2017] [Indexed: 12/22/2022] Open
Abstract
Cancer cell metastasis is responsible for most cancer deaths. Non-invasive in vivo cancer cell tracking in spontaneously metastasizing tumor models still poses a challenge requiring highest sensitivity and excellent contrast. The goal of this study was to evaluate if the recently introduced PET radiotracer [18F]tetrafluoroborate ([18F]BF4-) is useful for sensitive and specific metastasis detection in an orthotopic xenograft breast cancer model expressing the human sodium iodide symporter (NIS) as a reporter. In vivo imaging was complemented by ex vivo fluorescence microscopy and γ-counting of harvested tissues. Radionuclide imaging with [18F]BF4- (PET/CT) was compared to the conventional tracer [123I]iodide (sequential SPECT/CT). We found that [18F]BF4- was superior due to better pharmacokinetics, i.e. faster tumor uptake and faster and more complete clearance from circulation. [18F]BF4--PET was also highly specific as in all detected tissues cancer cell presence was confirmed microscopically. Undetected comparable tissues were similarly found to be free of metastasis. Metastasis detection by routine metabolic imaging with [18F]FDG-PET failed due to low standard uptake values and low contrast caused by adjacent metabolically active organs in this model. [18F]BF4--PET combined with NIS expressing disease models is particularly useful whenever preclinical in vivo cell tracking is of interest.
Collapse
Affiliation(s)
- S Diocou
- King's College London, Imaging Chemistry and Biology, Division of Imaging Sciences and Biomedical Engineering, 4th Floor Lambeth Wing, St. Thomas' Hospital, London, SE1 7EH, UK
| | - A Volpe
- King's College London, Imaging Chemistry and Biology, Division of Imaging Sciences and Biomedical Engineering, 4th Floor Lambeth Wing, St. Thomas' Hospital, London, SE1 7EH, UK
| | - M Jauregui-Osoro
- King's College London, Imaging Chemistry and Biology, Division of Imaging Sciences and Biomedical Engineering, 4th Floor Lambeth Wing, St. Thomas' Hospital, London, SE1 7EH, UK
| | - M Boudjemeline
- King's College London, Imaging Chemistry and Biology, Division of Imaging Sciences and Biomedical Engineering, 4th Floor Lambeth Wing, St. Thomas' Hospital, London, SE1 7EH, UK
| | - K Chuamsaamarkkee
- King's College London, Imaging Chemistry and Biology, Division of Imaging Sciences and Biomedical Engineering, 4th Floor Lambeth Wing, St. Thomas' Hospital, London, SE1 7EH, UK
| | - F Man
- King's College London, Imaging Chemistry and Biology, Division of Imaging Sciences and Biomedical Engineering, 4th Floor Lambeth Wing, St. Thomas' Hospital, London, SE1 7EH, UK
| | - P J Blower
- King's College London, Imaging Chemistry and Biology, Division of Imaging Sciences and Biomedical Engineering, 4th Floor Lambeth Wing, St. Thomas' Hospital, London, SE1 7EH, UK
| | - T Ng
- King's College London, The Richard Dimbleby Department of Cancer Research, Randall Division of Molecular Biophysics and Cancer Division, Guy's Campus, London, SE1 1UL, UK
- UCL, Cancer Institute, Paul O'Gorman Building, London, WC1E 6BT, UK
| | - G E D Mullen
- King's College London, Imaging Chemistry and Biology, Division of Imaging Sciences and Biomedical Engineering, 4th Floor Lambeth Wing, St. Thomas' Hospital, London, SE1 7EH, UK.
| | - G O Fruhwirth
- King's College London, Imaging Chemistry and Biology, Division of Imaging Sciences and Biomedical Engineering, 4th Floor Lambeth Wing, St. Thomas' Hospital, London, SE1 7EH, UK.
| |
Collapse
|
38
|
Genazzani AR, Petraglia F, Volpe A, Facchinetti F. Estrogen Changes as a Critical Factor in Modulation of Central Opioid Tonus: Possible Correlations with Post-Menopausal Migraine. Cephalalgia 2016. [DOI: 10.1177/03331024850050s241] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The effects exerted by ovarian steroids on the modulation of opioid activity were investigated in post-menopausal migraine sufferers and in healthy controls. In order to evaluate central opioid tonus, plasma LH rise after naloxone injection was measured, bearing in mind the tonic inhibition of endogenous opioid on hypothalamic LH-RH. There was no response of plasma LH to naloxone in post-menopausal women or in patients submitted to ovariectomy in fertile life. When the subjects underwent a sequencial estrogens + progestagens therapy, such a response was noted from the first month of treatment; progestagens alone were ineffective. The same phenomena were also evident in post-menopausal migraine sufferers. These data indicate that ovarian steroids modulate the activity of opiate receptors in both healthy women and migraine sufferers. Interestingly, replacement therapies through ovarian steroids restored the activity of central opioid tonus in patients affected by migraine.
Collapse
Affiliation(s)
- Andrea R Genazzani
- Department of Obstetrics and Gynecology, University of Modena, Via del Pozzo, 71, 41100 Modena, Italy
| | - Felice Petraglia
- Department of Obstetrics and Gynecology, University of Modena, Via del Pozzo, 71, 41100 Modena, Italy
| | - Annibale Volpe
- Department of Obstetrics and Gynecology, University of Modena, Via del Pozzo, 71, 41100 Modena, Italy
| | - Fabio Facchinetti
- Department of Obstetrics and Gynecology, University of Modena, Via del Pozzo, 71, 41100 Modena, Italy
| |
Collapse
|
39
|
Facchinetti F, Sances G, Volpe A, Sola D, D'ambrogio G, Sinforiani E, Genazzani AR. Hypothalamus pituitary-ovarian axis in menstrual migraine: effect of dihydroergotamine retard prophylactic treatment. Cephalalgia 2016. [DOI: 10.1177/03331024830030s126] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
LH, FSH, Prolactin (PRL), Estradiol (E) and Progesterone (P) plasma levels were measured in different periods of the menstrual cycle in 15 control subjects and in 9 women suffering from perimenstrual migraine before and after prophylactic treatment with 10 mg/day dihydroergotamine (DHE) retard. LH, FSH and PRL plasma levels were similar between patients and controls and were unaffected by DHE therapy. Migraineurs showed markedly reduced P levels in the entire luteal phase, concomitantly with higher E levels, leading to a P/E ratio significantly interfering with ovarian steroids secretion. These data indicate the presence of ovarian impairment in women suffering from perimenstrual migraine, whose symptoms could be successfully treated with DHE retard without interfering with the endocrine state. Les variations cicliques de LH, FSH, Prolactine (PRL) de la Estradiol (E) et de la Progesterone (P) ont ete evaluèes chez 15 subjets temoins et chez 9 femmes souffrant de la maladie migraineuse, en conditions de base et au cours d'un traitment prophilactique avec 10 mg par jour de Dihydroergotamine (DHE) rètard. LH, FSH et PRL etaient au meme niveau chez les temoins et les patients et n'ont pas ètè modifiès par le traitment avec DHE rètard; tandis que les taux plasmatiques de la P etaient rèduites et, au contraire, ceux de la E eatient elevèes pendant toute la phase luteale des migraineuses. Par consequence le rapport P/E les patientes etait significativement inferieur que chez les temoins. Le traitment avec la DHE rètard a presque totalement prevenue les accès migraineux, sans modifier le status normonal. Les femmes souffrant de maladie migraineuse au cours du cicle menstruel, notament dans la periode premenstruelle, montrent des affections de la secretion ovarienne qui doivent etre ancore expliquées. En tous cas las symptomatologie peut etre convenablement rèlevèe par le traitment prophilactique avec DHE rètard qui d'ailleur n'a aucune influence sur les secretions hypophisaires et ovariennes. I tassi plasmatici di LH, FSH, Prolattina (PRL), Estradiolo (E) e Progesterone (P) sono stati studiati nel corso del ciclo mestruale in 15 soggetti di controllo e in 9 pazienti affette da emicrania premestruale prima e dopo un trattamento profilattico con Diidroergotamina (DHE) ritardo (10 mg/die). LH, FSH e PRL sono risultati simili nei due gruppi e non ha mostrato variazioni in seguito al trattamento. Durante l'intera fase luteale, i tassi di P delle pazienti sono risultati significativamente ridotti, mentre quelli di E al contrario, erano più elevati, rispetto a quelli dei soggetti di controllo. La terapia con DHE ha pressoché abolito l'insorgenza degli attacchi emicranici, senza interferire con le concentrazioni di E e P. In conclusione, questi dati indicano che le pazienti affette da emicrania perimestruale presentano un'alterazione della funzione ovarica che resta da definire. Il trattamento profilattico conDHE ritardo però, è risultato efficacie nella abolizione delle crisi, senza interferire con le secrezioni ormonali.
Collapse
Affiliation(s)
- F. Facchinetti
- F. Facchinetti, Clinica Ostetrica e Ginecologica, Via del Pozzo, 71, 41100, Modena, Italy
| | - G. Sances
- F. Facchinetti, Clinica Ostetrica e Ginecologica, Via del Pozzo, 71, 41100, Modena, Italy
| | - A. Volpe
- F. Facchinetti, Clinica Ostetrica e Ginecologica, Via del Pozzo, 71, 41100, Modena, Italy
| | - D. Sola
- F. Facchinetti, Clinica Ostetrica e Ginecologica, Via del Pozzo, 71, 41100, Modena, Italy
| | - G. D'ambrogio
- F. Facchinetti, Clinica Ostetrica e Ginecologica, Via del Pozzo, 71, 41100, Modena, Italy
| | - E. Sinforiani
- F. Facchinetti, Clinica Ostetrica e Ginecologica, Via del Pozzo, 71, 41100, Modena, Italy
| | - A. R. Genazzani
- F. Facchinetti, Clinica Ostetrica e Ginecologica, Via del Pozzo, 71, 41100, Modena, Italy
| |
Collapse
|
40
|
Abstract
We measured reactivity to a stress paradigm during the premenstrual period in 19 women affected by Menstrually Related Disorders (MRD) and in 11 normal controls. Eight had premenstrual syndrome diagnosed by the Menstrual Distress Questionnaire and 11 suffered menstrual migraine, diagnosed according to International Headache Society criteria. Subjects were observed during two menstrual cycles and submitted to a psychocognitive test (Stroop Color Word) during the luteal phase. In both groups the stimulation by Stroop C-W was present for systolic blood pressure (SBP) (F = 18.14, p = 0.000), diastolic blood pressure (DBP) (F = 9.56, p = 0.000), and heart rate (F = 12.80, p = 0.000). Moreover, an interaction of response by group was present for DBP (2.58, p = 0.04); DBP values were higher in MRD subjects. Also baseline DBP values were higher in MRD with respect to controls. Area under the curve (AUC) subtracted from baseline for the SBP, DBP and heart rate did not differ between groups. In conclusion, MRD subjects facing a cognitive stress had normal cardiovascular response. However, patients had increased arousal of cardiovascular measures before and after testing. The significant differences during stress of testing were dissociated from those of experimental stress stimulation. MRD subjects may have less ability to cope with novelty than healthy volunteers.
Collapse
Affiliation(s)
- M Tarabusi
- Department of Gynaecological Obstetrics and Pediatric Sciences, University of Modena, Modena, Italy
| | - As Caputo
- Department of Gynaecological Obstetrics and Pediatric Sciences, University of Modena, Modena, Italy
| | - A Volpe
- Department of Gynaecological Obstetrics and Pediatric Sciences, University of Modena, Modena, Italy
| | - F Facchinetti
- Department of Gynaecological Obstetrics and Pediatric Sciences, University of Modena, Modena, Italy
| |
Collapse
|
41
|
Facchinetti F, Longo M, Piccinini F, Neri I, Volpe A. L-Arginine Infusion Reduces Blood Pressure in Preeclamptic Women Through Nitric Oxide Release. ACTA ACUST UNITED AC 2016. [DOI: 10.1177/107155769900600407] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- F. Facchinetti
- Department of Gynecology, Obstetrics, and Pediatric Sciences, University of Modena, Modena, Italy
| | | | | | | | - A. Volpe
- Department of Gynecology, Obstetrics, and Pediatric Sciences, University of Modena, Modena, Italy
| |
Collapse
|
42
|
Neri I, Fazzio M, Menghini S, Volpe A, Facchinetti F. Non-Stress Test Changes During Acupuncture Plus Moxibustion on BL67 Point in Breech Presentation. ACTA ACUST UNITED AC 2016. [DOI: 10.1177/107155760200900307] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Isabella Neri
- Clinica Ostetrica, Università di Roma-Tor Vergata, Rome, Italy, and Moderna e Reggio, Emilia, Italy
| | | | | | | | - Fabio Facchinetti
- Clinica Ostetrica, Università di Roma-Tor Vergata, Rome, Italy, and Moderna e Reggio, Emilia, Italy
| |
Collapse
|
43
|
La Marca A, De Leo V, Giulini S, Orvieto R, Malmusi S, Giannella L, Volpe A. Anti-Mullerian Hormone in Premenopausal Women and After Spontaneous or Surgically Induced Menopause. ACTA ACUST UNITED AC 2016; 12:545-8. [PMID: 16046154 DOI: 10.1016/j.jsgi.2005.06.001] [Citation(s) in RCA: 89] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2005] [Indexed: 11/21/2022]
Abstract
OBJECTIVE The objectives of this study were: (1) to determine anti-Mullerian hormone (AMH) levels in menopausal women, and (2) to confirm the source of AMH in cycling women and its disappearance after the removal of the source. METHODS An observational and prospective study was conducted. RESULTS A total of 47 women were recruited for the study. The study population consisted of the following groups of patients: (A) women of late reproductive age (n = 24; mean age +/- SD, 44 +/- 2.8 years); (B) menopausal women (n =14; mean age, 56 +/- 4 years); and (C) regularly cycling women undergoing surgical menopause (n = 9; mean age, 43 +/- 4 years). Blood samples were obtained from all patients. In patients undergoing surgery, blood samples were obtained before and after surgery. AMH was undetectable in 13 of 14 postmenopausal women, whereas it was undetectable in only two of 24 women of late reproductive age. A significant negative correlation has been found between AMH and age or follicle-stimulating hormone (FSH) in women of late reproductive age. In women who were candidates for oophorectomy, samples were obtained 3-5 days after surgery. AMH was undetectable after the surgery in all women. CONCLUSIONS We found that AMH levels decreased in women in the late reproductive period and that menopause and ovariectomy in regularly cycling women are associated to undetectable AMH in serum. These observations confirm that the ovary could be the only source of AMH in women and that it is a novel marker for ovarian aging.
Collapse
|
44
|
Affiliation(s)
| | | | - A. Volpe
- Departments of Gynecological, Obstetric, and Pediatric Sciences, and De-partment of Pathology and Legal Medicine, University of Modena and Reggio, Emilia, Italy
| | - F. Facchinetti
- Departments of Gynecological, Obstetric, and Pediatric Sciences, and De-partment of Pathology and Legal Medicine, University of Modena and Reggio, Emilia, Italy; Policlinic di Modena, Via del Pozzo, 71, 41100 Modena, Italy
| |
Collapse
|
45
|
Sakellariou G, Bellis E, Scirè C, Carrara G, Adinolfi A, Bortoluzzi A, Batticciotto A, Cagnotto G, Caprioli M, Canzoni M, Cavatorta F, De Lucia O, Di Sabatino V, Draghessi A, Filippou G, Farina I, Focherini M, Gabba A, Gutierrez M, Idolazzi L, Luccioli F, Macchioni P, Massarotti M, Mastaglio C, Menza L, Muratore M, Parisi S, Picerno V, Piga M, Ramonda R, Raffeiner B, Rossi D, Rossi S, Rossini P, Scioscia C, Venditti C, Volpe A, Matucci-Cerinic M, Iagnocco A. SAT0061 Concurrent Ultrasound-Detected Synovitis and Tenosynovitis Predict Flare in Patients with Rheumatoid Arthritis in Clinical Remission. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.4747] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
46
|
Berti A, Felicetti M, Volpe A, Bortolotti R, Cavatorta F, Barausse G, Peccatori S, Leveghi L, Pedrotti C, Paolazzi G. SAT0491 Higher Levels of anti-Borrelia IGG Associate with Arthritis in Lyme Disease at Presentation: A Northern Italy Referral Center Cohort. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.6113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
47
|
Krengli M, Beldì D, Apicella G, Marchioro G, Pisani C, Ferrara E, Perotti C, Loi G, Volpe A, Terrone C. EP-1346: Intraoperative radioterapy (IORT) in the multimodality treatment of locally advanced prostate cancer. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32596-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
48
|
Capitanio U, Stewart G, Klatte T, Volpe A, Akdogan B, Roscigno M, Langenhuijsen H, Marszalek M, Rodriguez Faba O, Salagierski M, Minervini A, Brookman-May S. 522 Temporal trends in the rate of lymph node dissection for renal cell carcinoma. ACTA ACUST UNITED AC 2016. [DOI: 10.1016/s1569-9056(16)60524-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Barillà D, Massara M, Volpe A, Versace P, Volpe P. Re: ‘How Should I Treat a Patient with a Tandem Carotid Artery Atherosclerotic Stenosis Involving the Internal Carotid Artery and the Innominate/Proximal Common Carotid Artery?’. Eur J Vasc Endovasc Surg 2016; 51:313-4. [DOI: 10.1016/j.ejvs.2015.10.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2015] [Accepted: 10/10/2015] [Indexed: 11/30/2022]
|
50
|
Grandi G, Mueller M, Bersinger NA, Cagnacci A, Volpe A, McKinnon B. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflamm Res 2015; 65:183-92. [PMID: 26650031 DOI: 10.1007/s00011-015-0909-7] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2015] [Revised: 11/18/2015] [Accepted: 11/19/2015] [Indexed: 01/16/2023] Open
Abstract
OBJECTIVE AND DESIGN A systematic review of all literature was done to assess the ability of the progestin dienogest (DNG) to influence the inflammatory response of endometriotic cells. MAIN OUTCOME MEASURES In vitro and in vivo studies report an influence of DNG on the inflammatory response in eutopic or ectopic endometrial tissue (animal or human). RESULTS After strict inclusion criteria were satisfied, 15 studies were identified that reported a DNG influence on the inflammatory response in endometrial tissue. These studies identified a modulation of prostaglandin (PG) production and metabolism (PGE2, PGE2 synthase, cyclo-oxygenase-2 and microsomal PGE synthase-1), pro-inflammatory cytokine and chemokine production [interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor-α, monocyte chemoattractant protein-1 and stromal cell-derived factor-1], growth factor biosynthesis (vascular endothelial growth factor and nerve growth factor) and signaling kinases, responsible for the control of inflammation. Evidence supports a progesterone receptor-mediated inhibition of the inflammatory response in PR-expressing epithelial cells. It also indicated that DNG inhibited the inflammatory response in stromal cells, however, whether this was via a PR-mediated mechanism is not clear. CONCLUSIONS DNG has a significant effect on the inflammatory microenvironment of endometriotic lesions that may contribute to its clinical efficacy. A better understanding of the specific anti-inflammatory activity of DNG and whether this contributes to its clinical efficacy can help develop treatments that focus on the inhibition of inflammation while minimizing hormonal modulation.
Collapse
Affiliation(s)
- Giovanni Grandi
- Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, Via del Pozzo 71, 41124, Modena, Italy.,Department of Clinical Research, University of Berne, Murtenstrasse 35, 3010, Berne, Switzerland
| | - Michael Mueller
- Department of Obstetrics and Gynaecology, Inselspital, Berne University Hospital, Effingerstrasse 102, 3010, Berne, Switzerland.,Department of Clinical Research, University of Berne, Murtenstrasse 35, 3010, Berne, Switzerland
| | - Nick A Bersinger
- Department of Obstetrics and Gynaecology, Inselspital, Berne University Hospital, Effingerstrasse 102, 3010, Berne, Switzerland.,Department of Clinical Research, University of Berne, Murtenstrasse 35, 3010, Berne, Switzerland
| | - Angelo Cagnacci
- Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, Via del Pozzo 71, 41124, Modena, Italy
| | - Annibale Volpe
- Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, Via del Pozzo 71, 41124, Modena, Italy
| | - Brett McKinnon
- Department of Obstetrics and Gynaecology, Inselspital, Berne University Hospital, Effingerstrasse 102, 3010, Berne, Switzerland. .,Department of Clinical Research, University of Berne, Murtenstrasse 35, 3010, Berne, Switzerland.
| |
Collapse
|